<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1520" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1520/" /><meta name="ncbi_pagename" content="MERRF - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>MERRF - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="MERRF" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/01/29" /><meta name="citation_author" content="Salvatore DiMauro" /><meta name="citation_author" content="Michio Hirano" /><meta name="citation_pmid" content="20301693" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1520/" /><meta name="citation_keywords" content="Myoclonic Epilepsy Associated with Ragged Red Fibers" /><meta name="citation_keywords" content="Myoclonic Epilepsy Associated with Ragged-Red Fibers" /><meta name="citation_keywords" content="MT-TF" /><meta name="citation_keywords" content="MT-TI" /><meta name="citation_keywords" content="MT-TK" /><meta name="citation_keywords" content="MT-TL1" /><meta name="citation_keywords" content="MT-TP" /><meta name="citation_keywords" content="MERRF" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="MERRF" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Salvatore DiMauro" /><meta name="DC.Contributor" content="Michio Hirano" /><meta name="DC.Date" content="2015/01/29" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1520/" /><meta name="description" content="MERRF (myoclonic epilepsy with ragged red fibers) is a multisystem disorder characterized by myoclonus (often the first symptom) followed by generalized epilepsy, ataxia, weakness, and dementia. Onset is usually in childhood, occurring after normal early development. Common findings are hearing loss, short stature, optic atrophy, and cardiomyopathy with Wolff-Parkinson-White (WPW) syndrome. Pigmentary retinopathy and lipomatosis are occasionally observed." /><meta name="og:title" content="MERRF" /><meta name="og:type" content="book" /><meta name="og:description" content="MERRF (myoclonic epilepsy with ragged red fibers) is a multisystem disorder characterized by myoclonus (often the first symptom) followed by generalized epilepsy, ataxia, weakness, and dementia. Onset is usually in childhood, occurring after normal early development. Common findings are hearing loss, short stature, optic atrophy, and cardiomyopathy with Wolff-Parkinson-White (WPW) syndrome. Pigmentary retinopathy and lipomatosis are occasionally observed." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1520/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/merrf/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1520/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE899FEAE04128A10000000001490094.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1520_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1520_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/melas/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mpph/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1520_"><span class="title" itemprop="name">MERRF</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Myoclonic Epilepsy Associated with Ragged Red Fibers</div><p class="contrib-group"><span itemprop="author">Salvatore DiMauro</span>, MD and <span itemprop="author">Michio Hirano</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1520_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1520_ai__"><div class="contrib half_rhythm"><span itemprop="author">Salvatore DiMauro</span>, MD<div class="affiliation small">H Houston Merritt Center<br />Department of Neurology<br />Columbia University Medical Center<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.aibmuloc@21ds" class="oemail">ude.aibmuloc@21ds</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Michio Hirano</span>, MD<div class="affiliation small">H Houston Merritt Center<br />Department of Neurology<br />Columbia University Medical Center<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.aibmuloc@92hm" class="oemail">ude.aibmuloc@92hm</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 3, 2003</span>; Last Update: <span itemprop="dateModified">January 29, 2015</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="merrf.Summary" itemprop="description"><h2 id="_merrf_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>MERRF (<i>m</i>yoclonic <i>e</i>pilepsy with <i>r</i>agged <i>r</i>ed <i>f</i>ibers) is a multisystem disorder characterized by myoclonus (often the first symptom) followed by generalized epilepsy, ataxia, weakness, and dementia. Onset is usually in childhood, occurring after normal early development. Common findings are hearing loss, short stature, optic atrophy, and cardiomyopathy with Wolff-Parkinson-White (WPW) syndrome. Pigmentary retinopathy and lipomatosis are occasionally observed.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The clinical diagnosis of MERRF is based on the following four "canonic" features: myoclonus, generalized epilepsy, ataxia, and ragged red fibers (RRF) in the muscle biopsy. The mitochondrial DNA (mtDNA) <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>MT-TK</i> encoding tRNA<sup>Lys</sup> is the gene most commonly associated with MERRF. The most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, present in more than 80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with typical findings, is an A-to-G transition at nucleotide 8344 (m.8344A&#x0003e;G). Pathogenic variants in <i>MT-TF</i>, <i>MT-TL1</i>, <i>MT-TI</i>, and <i>MT-TP</i> have also been described in a subset of individuals with MERRF. Pathogenic variants are usually present in all tissues and are conveniently detected in mtDNA from blood leukocytes. However, the occurrence of "<a class="def" href="/books/n/gene/glossary/def-item/heteroplasmy/">heteroplasmy</a>" in disorders of mtDNA can result in varying tissue distribution of mutated mtDNA. Hence, in individuals having few symptoms consistent with MERRF or in asymptomatic maternal relatives of an affected individual, the pathogenic variant may be undetectable in mtDNA from leukocytes and may only be detected in other tissues, such as cultured skin fibroblasts, urinary sediment, oral mucosa, saliva, hair follicles, or (most reliably) skeletal muscle.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Conventional antiepileptic drugs for seizures; physical therapy to improve any impaired motor function; aerobic exercise; standard pharmacologic therapy for cardiac symptoms. Levetiracetam, clonazepam, zonisamide, and valproic acid (VPA) have been used to treat myoclonic epilepsy; however, VPA may cause secondary carnitine deficiency and should be avoided or used with L-carnitine supplementation.</p><p><i>Prevention of primary manifestations:</i> Coenzyme Q<sub>10</sub> (50-100 mg 3x/day) and L-carnitine (1000 mg 3x/day) are often used in hopes of improving mitochondrial function.</p><p><i>Surveillance:</i> Routine evaluations every 6-12 months initially; annual neurologic, ophthalmologic, cardiology (electrocardiogram and echocardiogram), and endocrinologic evaluations (fasting blood sugar and TSH) evaluations.</p><p><i>Pregnancy management:</i> During pregnancy, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at-risk women should be monitored for diabetes mellitus and respiratory insufficiency, which may require therapeutic interventions.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>MERRF is caused by pathogenic variants in mtDNA and is transmitted by maternal inheritance. The father of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is not at risk for having the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The mother of a proband usually has the mtDNA pathogenic variant and may or may not have symptoms. A male with a mtDNA pathogenic variant cannot transmit the pathogenic variant to any of his offspring. A female with the pathogenic variant (whether <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or unaffected) transmits the pathogenic variant to all of her offspring. Prenatal diagnosis for MERRF is possible if an mtDNA pathogenic variant has been detected in the mother. However, because the mutational load in the mother's tissues and in the fetal tissues sampled (i.e., amniocytes and chorionic villi) may not correspond to that of other fetal tissues and because the mutational load in tissues sampled prenatally may shift in utero or after birth secondary to random mitotic segregation, prediction of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> from prenatal studies is not possible.</p></div></div><div id="merrf.Diagnosis"><h2 id="_merrf_Diagnosis_">Diagnosis</h2><div id="merrf.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The clinical diagnosis of MERRF (<i>m</i>yoclonic <i>e</i>pilepsy with <i>r</i>agged <i>r</i>ed <i>f</i>ibers) is based on the following four "canonic" features:</p><ul><li class="half_rhythm"><div>Myoclonus</div></li><li class="half_rhythm"><div>Generalized epilepsy</div></li><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Ragged-red fibers (RRF) in the muscle biopsy or identification of a mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></div></li></ul><p>Additional frequent manifestations include the following:</p><ul><li class="half_rhythm"><div>Sensorineural hearing loss</div></li><li class="half_rhythm"><div>Myopathy</div></li><li class="half_rhythm"><div>Peripheral neuropathy</div></li><li class="half_rhythm"><div>Dementia</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Exercise intolerance</div></li><li class="half_rhythm"><div>Optic atrophy</div></li></ul><p>Less common clinical signs (seen in &#x0003c;50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) include the following:</p><ul><li class="half_rhythm"><div>Cardiomyopathy</div></li><li class="half_rhythm"><div>Pigmentary retinopathy</div></li><li class="half_rhythm"><div>Pyramidal signs</div></li><li class="half_rhythm"><div>Ophthalmoparesis</div></li><li class="half_rhythm"><div>Multiple lipomas</div></li></ul></div><div id="merrf.Testing"><h3>Testing</h3><p><b>Lactic acidosis both in blood and in the CSF.</b> In individuals with MERRF, the concentrations of lactate and pyruvate are commonly elevated at rest and increase excessively after moderate activity.</p><p>Note: Other situations (unrelated to the diagnosis of MERRF or other mitochondrial diseases) in which lactate and pyruvate can be elevated are acute neurologic events such as seizure or stroke.</p><p><b>Elevated CSF protein concentration.</b> The concentration of CSF protein may be increased but rarely surpasses 100 mg/dL.</p><p><b>Electroencephalogram (EEG)</b> usually shows generalized spike and wave discharges with background slowing, but focal epileptiform discharges may also be seen.</p><p><b>Electrocardiogram</b> often shows pre-excitation; heart block has not been described.</p><p><b>Electromyogram (EMG)</b> and <b>nerve conduction velocity (NCV)</b> studies are consistent with a myopathy, but neuropathy may coexist.</p><p><b>Brain MRI</b> often shows brain atrophy and basal ganglia calcification. Bilateral putaminal necrosis and atrophy of the brain stem and cerebellum have been reported [<a class="bk_pop" href="#merrf.REF.orcesi.2006.79">Orcesi et al 2006</a>, <a class="bk_pop" href="#merrf.REF.ito.2008.392">Ito et al 2008</a>].</p><p><b>Muscle biopsy</b> typically shows ragged red fibers (RRF) with the modified Gomori trichrome stain and hyperactive fibers with the succinate dehydrogenase (SDH) stain. Both RRF and some non-RRF fail to stain with the histochemical reaction for cytochrome <i>c</i> oxidase (COX). Occasionally, RRF may not be observed [<a class="bk_pop" href="#merrf.REF.mancuso.2007.1058">Mancuso et al 2007</a>].</p><p><b>Respiratory chain studies.</b> Biochemical analysis of respiratory chain enzymes in muscle extracts usually shows decreased activity of respiratory chain complexes containing mtDNA-encoded subunits, especially COX deficiency. However, biochemical studies may also be normal.</p><p><b>Genes.</b>
<i>MT-TK</i>, <i>MT-TF</i>, <i>MT-TL1</i>, <i>MT-TI</i>, and <i>MT-TP</i> are the genes in which pathogenic variants are known to cause MERRF.</p><div id="merrf.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in MERRF</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1520/table/merrf.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__merrf.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TK</i></td><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis of m.8344A&#x0003e;G</td><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;80%&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants&#x000a0;<sup>3</sup></td><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~10%&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TF</i></td><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis / scanning for pathogenic variants&#x000a0;<sup>4,&#x000a0;5</sup></td><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TL1</i></td></tr><tr><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TI</i></td></tr><tr><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TP</i></td></tr><tr><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">mtDNA</td><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis / scanning for pathogenic variants <sup>4</sup></td><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%-95%&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_merrf.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="merrf.TF.1.1"><p class="no_margin">See <a href="/books/NBK1520/#merrf.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#merrf.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="merrf.TF.1.2"><p class="no_margin">Four <i>MT-TK</i> pathogenic variants (<a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.8344A&#x0003e;G</a>, <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.8356T&#x0003e;C</a>, <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.8363G&#x0003e;A</a>, and <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.8361G&#x0003e;A</a>) account for approximately 90% of pathogenic variants in individuals with MERRF.</p></div></dd><dt>3. </dt><dd><div id="merrf.TF.1.3"><p class="no_margin">Pathogenic variants detected: m.8356T&#x0003e;C, m.8363G&#x0003e;A, and m.8361G&#x0003e;A. Note: Pathogenic variants included in a panel may vary by laboratory.</p></div></dd><dt>4. </dt><dd><div id="merrf.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, partial-, whole-, or multigene deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="merrf.TF.1.5"><p class="no_margin">Pathogenic variants detected: <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.611G&#x0003e;A</a>, <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.3243A.G</a>, <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.4279A&#x0003e;G</a>, <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.4284G&#x0003e;A</a>, and <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.15967G&#x0003e;A</a></p></div></dd><dt>6. </dt><dd><div id="merrf.TF.1.6"><p class="no_margin">The proportion of MERRF caused by the pathogenic variants listed in footnote 4</p></div></dd><dt>7. </dt><dd><div id="merrf.TF.1.7"><p class="no_margin">Sequence analysis / scanning for pathogenic variants is used to detect pathogenic variants throughout mtDNA and is not specific for MERRF. The overall variant detection rate for MERRF by scanning/<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of mtDNA is 90%-95%.</p></div></dd><dt>8. </dt><dd><div id="merrf.TF.1.8"><p class="no_margin">One child with MERRF was found to have two mtDNA deletions in a buccal swab suggesting an <a class="def" href="/books/n/gene/glossary/def-item/autosomal/">autosomal</a> disorder with multiple mtDNA deletions; however, the causative nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> was not identified [<a class="bk_pop" href="#merrf.REF.yorns.2012.398">Yorns et al 2012</a>].</p></div></dd></dl></div></div></div></div><div id="merrf.Testing_Strategy"><h3>Testing Strategy</h3><div id="merrf.Establishing_the_Diagnosis_in_a_Pr"><h4>Establishing the Diagnosis in a Proband</h4><p>Pathogenic variants are usually present in all tissues and can be detected in mtDNA from blood leukocytes in individuals with typical MERRF; however the occurrence of "<a class="def" href="/books/n/gene/glossary/def-item/heteroplasmy/">heteroplasmy</a>" in disorders of mtDNA can result in varying tissue distribution of mutated mtDNA. Hence, in individuals having few symptoms consistent with MERRF or in asymptomatic maternal relatives, the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may be undetectable in mtDNA from leukocytes and may only be detected in other tissues, such as cultured skin fibroblasts, urinary sediment, oral mucosa, saliva, hair follicles, or (most reliably) skeletal muscle.</p><p><b>One genetic testing strategy</b> is serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> based on the order in which pathogenic variants most commonly occur:</p><ul><li class="half_rhythm"><div class="half_rhythm">Typically, blood leukocyte DNA is initially screened for pathogenic variants in <i>MT-TK</i> using targeted analysis for the <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.8344A&#x0003e;G</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> followed by screening for the <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.8356T&#x0003e;C</a>, <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.8363G&#x0003e;A</a>, and <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.8361G&#x0003e;A</a> pathogenic variants.</div><div class="half_rhythm">Alternatively, DNA from buccal mucosa, muscle, or urine sediment can be screened for mtDNA pathogenic variants.</div></li><li class="half_rhythm"><div class="half_rhythm">If the four most frequent <i>MT-TK</i> pathogenic variants are excluded, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>MT-TF, MT-TL1, MT-TI,</i> and <i>MT-TP</i> may be considered.</div><div class="half_rhythm">Note: In <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) with myoclonus, epilepsy, and ataxia, muscle biopsy is often useful in detecting signs of mitochondrial dysfunction such as ragged red fibers, cytochrome <i>c</i> oxidase-deficient fibers, or biochemical defects of mitochondrial respiratory chain enzymes.</div></li></ul><p><b>An alternative genetic testing strategy</b> is use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>MT-TK</i>, <i>MT-TF</i>, <i>MT-TL1, MT-TI,</i> and <i>MT-TP,</i> and other genes of interest (see <a href="#merrf.Differential_Diagnosis">Differential Diagnosis</a>) or full mtDNA sequencing. Note: The genes included and the methods used in multigene panels vary by laboratory and are likely to change over time.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div></div></div><div id="merrf.Clinical_Characteristics"><h2 id="_merrf_Clinical_Characteristics_">Clinical Characteristics</h2><div id="merrf.Clinical_Description"><h3>Clinical Description</h3><p>MERRF is a multisystem disorder characterized by myoclonus, which is often the first symptom, followed by generalized epilepsy, ataxia, weakness, and dementia. Onset is usually in childhood, after normal early development. <a class="figpopup" href="/books/NBK1520/table/merrf.T.signs_and_symptoms_seen_in_62_in/?report=objectonly" target="object" rid-figpopup="figmerrfTsignsandsymptomsseenin62in" rid-ob="figobmerrfTsignsandsymptomsseenin62in">Table 2</a> lists the symptoms and signs seen in 62 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#merrf.REF.hirano.1996">Hirano &#x00026; DiMauro 1996</a>]. About 80% (34/42) had a family history compatible with maternal inheritance, but not all maternal relatives were affected and not all of those affected had classic features of MERRF. For example, seven symptomatic relatives had "limb-girdle myopathy" as the only manifestation. Depression may be an under-recognized feature of MERRF [<a class="bk_pop" href="#merrf.REF.molnar.2009.264">Molnar et al 2009</a>].</p><p>Cardiac involvement has been reported to be frequent in individuals with the <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.8344A&#x0003e;G</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MT-TK</i> [<a class="bk_pop" href="#merrf.REF.wahbi.2010.674">Wahbi et al 2010</a>]. At diagnosis, eight (44%) of 18 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had cardiac abnormalities including: dilated cardiomyopathy in four, Wolff-Parkinson-White syndrome in three, incomplete left bundle branch block in one, and premature ventricular beats in one. On follow up, two additional affected individuals developed left ventricular dysfunction and two died of heart failure.</p><p>Occasionally individuals fulfilling the clinical criteria for MERRF also have strokes (MERRF/<a href="/books/n/gene/melas/">MELAS</a> overlap) [<a class="bk_pop" href="#merrf.REF.crimi.2003.1857">Crimi et al 2003</a>, <a class="bk_pop" href="#merrf.REF.melone.2004.269">Melone et al 2004</a>, <a class="bk_pop" href="#merrf.REF.naini.2005.473">Naini et al 2005</a>] or progressive external ophthalmoplegia and retinopathy, reminiscent of <a href="/books/n/gene/kss/">Kearns-Sayre syndrome</a> [<a class="bk_pop" href="#merrf.REF.nishigaki.2003.334">Nishigaki et al 2003</a>, <a class="bk_pop" href="#merrf.REF.emmanuele.2011.448">Emmanuele et al 2011</a>, <a class="bk_pop" href="#merrf.REF.fujioka.2014.13">Fujioka et al 2014</a>].</p><p>Maternally inherited spinocerebellar degeneration and Leigh syndrome, atypical Charcot-Marie-Tooth disease (see <a href="/books/n/gene/cmt/">Charcot-Marie-Tooth Overview</a>), and Leigh syndrome have been reported as unusual manifestations in families with individuals diagnosed with MERRF.</p><p>High clinical variability is seen in individuals with the <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.8344A&#x0003e;G</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MT-TK</i>. In a retrospective analysis of 42 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals plus 282 previously reported individuals with this pathogenic variant, the large majority did not have all four of the canonic features of MERRF. The most common clinical features, in descending order of frequency, were: myoclonus, muscle weakness, ataxia (35%-45%); generalized seizures, hearing loss (25%-34.9%); cognitive impairment, multiple lipomatosis, neuropathy, exercise intolerance (15%-24.9%); and elevated creatine kinase, ptosis/PEO, optic atrophy, cardiomyopathy, muscle wasting, respiratory impairment, diabetes, myalgias, tremor, and migraine headaches (5%-14.9%) [<a class="bk_pop" href="#merrf.REF.mancuso.2013.2049">Mancuso et al 2013</a>].</p><p>Unusual manifestations in individuals with the <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.8344A&#x0003e;G</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MT-TK</i> include the following:</p><ul><li class="half_rhythm"><div>Sudden infant death syndrome (SIDS) in an infant girl who had an unsuspected cardiomyopathy with the histologic features of histiocytoid cardiomyopathy [<a class="bk_pop" href="#merrf.REF.vallance.2004.538">Vallance et al 2004</a>]</div></li><li class="half_rhythm"><div>Spasmodic dysphonia in a woman age 46 years with otherwise fairly typical personal and family history of MERRF [<a class="bk_pop" href="#merrf.REF.peng.2003.716">Peng et al 2003</a>]</div></li><li class="half_rhythm"><div>Resting muscle pain as the initial symptom in children [<a class="bk_pop" href="#merrf.REF.van_de_glind.2007.243">van de Glind et al 2007</a>]</div></li><li class="half_rhythm"><div>Myoclonus, epilepsy, and ataxia without ragged red fibers [<a class="bk_pop" href="#merrf.REF.mancuso.2007.1058">Mancuso et al 2007</a>]</div></li><li class="half_rhythm"><div>Parkinsonism, neuropathy, and myopathy [<a class="bk_pop" href="#merrf.REF.horvath.2007.56">Horvath et al 2007</a>]</div></li><li class="half_rhythm"><div>Infantile-onset ataxia, myoclonus, and bilateral putaminal necrosis on brain MRI [<a class="bk_pop" href="#merrf.REF.orcesi.2006.79">Orcesi et al 2006</a>]</div></li><li class="half_rhythm"><div>Sudden respiratory failure in adulthood [<a class="bk_pop" href="#merrf.REF.wiedemann.2008.859">Wiedemann et al 2008</a>]</div></li><li class="half_rhythm"><div>Acute central and peripheral nervous system demyelinating disease [<a class="bk_pop" href="#merrf.REF.erol.2009.275">Erol et al 2009</a>]</div></li><li class="half_rhythm"><div>Stroke-like episodes similar to MELAS [<a class="bk_pop" href="#merrf.REF.vastagh.2011.399">Vastagh et al 2011</a>]</div></li><li class="half_rhythm"><div>Distal limb weakness along with ptosis and respiratory muscle weakness [<a class="bk_pop" href="#merrf.REF.blakely.2014.533">Blakely et al 2014</a>]</div></li></ul><p>A boy age six years with the <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.8631G&#x0003e;A</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MT-TK</i> developed seizures and myoclonus, followed by ataxia, cognitive impairment, and sensorineural hearing loss. Maternal relatives were oligosymptomatic [<a class="bk_pop" href="#merrf.REF.rossmanith.2003.820">Rossmanith et al 2003</a>].</p><p>An individual with the <i>MT-TF</i>
<a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.611G&#x0003e;A</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> had mild truncal and proximal limb weakness, cerebellar ataxia, bilateral Babinski sign, and frequent myoclonic jerks [<a class="bk_pop" href="#merrf.REF.mancuso.2004.2119">Mancuso et al 2004</a>].</p><div id="merrf.T.signs_and_symptoms_seen_in_62_in" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Signs and Symptoms Seen in 62 Individuals with MERRF</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1520/table/merrf.T.signs_and_symptoms_seen_in_62_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__merrf.T.signs_and_symptoms_seen_in_62_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sign/Symptom</th><th id="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Present/Evaluated</th><th id="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Percentage</th></tr></thead><tbody><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonus</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">62/62</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Epilepsy</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">62/62</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal early development</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17/17</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">RRF (ragged red fibers)</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">47/51</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">92%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hearing loss</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">41/45</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">91%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lactic acidosis</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">24/29</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">83%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Family history</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">34/42</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">81%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exercise intolerance</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8/10</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">80%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dementia</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">39/52</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">75%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuropathy</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17/27</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">63%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Short stature</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/7</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">57%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired sensation</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9/18</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Optic atrophy</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14/36</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">39%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiomyopathy</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/6</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">33%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Wolff-Parkinson-White syndrome</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/9</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pigmentary retinopathy</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/26</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pyramidal signs</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8/60</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmoparesis</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/28</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11%</td></tr><tr><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lipomatosis</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/60</td><td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#merrf.REF.hirano.1996">Hirano &#x00026; DiMauro [1996]</a></p></div></dd></dl></div></div></div></div><div id="merrf.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No clear correlation has been identified between <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> and clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, nor is it clear why typical MERRF is associated with pathogenic variants in <i>MT-TK</i>.</p><p>For all mtDNA pathogenic variants, clinical expression depends on three factors:</p><ul><li class="half_rhythm"><div><b>Heteroplasmy.</b> The relative abundance of mutated mtDNAs</div></li><li class="half_rhythm"><div><b>Tissue distribution</b> of mutated mtDNAs</div></li><li class="half_rhythm"><div><b>Threshold effect.</b> The vulnerability of each tissue to impaired oxidative metabolism</div></li></ul><p>The tissue vulnerability threshold probably does not vary substantially among individuals, but variable mutational load and tissue distribution may account for the clinical diversity of individuals with MERRF.</p><p>The selective vulnerability of the dentate nucleus of the cerebellum and the olivary nucleus of the medulla is unexplained. Also unexplained is the pathogenesis of the multiple lipomas characteristically associated with pathogenic variants in <i>MT-TK</i>.</p></div><div id="merrf.Penetrance"><h3>Penetrance</h3><p>See <a href="#merrf.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>.</p></div><div id="merrf.Anticipation"><h3>Anticipation</h3><p>No evidence of <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> has been found, but knowledge of the molecular defect may favor earlier diagnosis in subsequent generations.</p></div><div id="merrf.Nomenclature"><h3>Nomenclature</h3><p>Ramsay <a class="bk_pop" href="#merrf.REF.hunt.1921.490">Hunt [1921]</a> described six individuals with a disorder characterized by ataxia, myoclonus, and epilepsy, which he called "dyssynergia cerebellaris myoclonica." Individuals with the diagnosis of Ramsay Hunt syndrome should be investigated for MERRF.</p></div><div id="merrf.Prevalence"><h3>Prevalence</h3><p>Three epidemiologic studies of mtDNA-related diseases in northern Europe gave concordantly low estimates for the prevalence of the m.8344A&#x0003e;G <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>:</p><ul><li class="half_rhythm"><div>0-1.5:100,000 in the adult population of northern Finland [<a class="bk_pop" href="#merrf.REF.remes.2005.976">Remes et al 2005</a>]</div></li><li class="half_rhythm"><div>0.39:100,000 in the adult population of northern England [<a class="bk_pop" href="#merrf.REF.schaefer.2008.35">Schaefer et al 2008</a>]</div></li><li class="half_rhythm"><div>0-0.25:100,000 in a pediatric population of western Sweden [<a class="bk_pop" href="#merrf.REF.darin.2001.377">Darin et al 2001</a>]</div></li></ul><p>See <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a> for general prevalence information.</p></div></div><div id="merrf.Genetically_Related_Allelic_Disord"><h2 id="_merrf_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p><b><i>MT-TK</i></b></p><ul><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond"><b>m.8344A&#x0003e;G</b></a> can also be associated with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> myopathy, resembling limb-girdle muscular dystrophy, or with multiple lipomas, usually located in the neck and shoulders area (Ekbom syndrome). Other clinical presentations of the m.8344A&#x0003e;G <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include spinocerebellar degeneration and <a href="/books/n/gene/narp/">Leigh syndrome</a> or isolated Leigh syndrome.</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond"><b>m.8356T&#x0003e;C</b></a><b>.</b> In three families with the m.8356T&#x0003e;C <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had typical MERRF but others also had stroke-like episodes and migraine (MERRF/<a href="/books/n/gene/melas/">MELAS</a> overlap).</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond"><b>m.8363G&#x0003e;A</b></a> has been associated with typical MERRF, but also with cardiomyopathy or Leigh syndrome [<a class="bk_pop" href="#merrf.REF.shtilbans.2000.759">Shtilbans et al 2000</a>].</div></li></ul><p><b><i>MT-TL1</i></b></p><ul><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond"><b>m.3243A&#x0003e;G</b></a> is associated with multiple phenotypes including MELAS (<i>m</i>itochondrial <i>e</i>ncephalomyopathy, <i>l</i>actic <i>a</i>cidosis, and <i>s</i>troke-like episodes), maternally inherited diabetes and deafness (MIDD), and chronic progressive external ophthalmoplegia (CPEO).</div></li><li class="half_rhythm"><div>A MERRF/<a href="/books/n/gene/kss/">Kearns-Sayre syndrome</a> (KSS) overlap syndrome has been reported to be caused by the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> m.3255G&#x0003e;A in <i>MT-TL1</i> (reported in two individuals [<a class="bk_pop" href="#merrf.REF.nishigaki.2003.334">Nishigaki et al 2003</a>, <a class="bk_pop" href="#merrf.REF.fujioka.2014.13">Fujioka et al 2014</a>]) and by the pathogenic variant m.3291T&#x0003e;C in <i>MT-TL1</i> (reported in one individual [<a class="bk_pop" href="#merrf.REF.emmanuele.2011.448">Emmanuele et al 2011</a>]).</div></li></ul><p><b><i>MT-TI</i></b></p><ul><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond"><b>m.15923A&#x0003e;G</b></a> has been associated with neonatal weakness, lactic acidosis, hypoglycemia, cardiopulmonary arrest, and early fatality in one individual [<a class="bk_pop" href="#merrf.REF.yoon.1993.433">Yoon et al 1993</a>].</div></li></ul><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>MT-TF</i> or <i>MT-TP</i>.</p></div><div id="merrf.Differential_Diagnosis"><h2 id="_merrf_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Neurologic findings.</b> The differential diagnosis includes the following:</p><ul><li class="half_rhythm"><div>Other mitochondrial disorders (see <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/alpers/"><b><i>POLG</i>-related disorders</b></a><b>.</b> One individual with myoclonus, epilepsy, ataxia, peripheral neuropathy, but no ragged red fibers had <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> pathogenic variants in <i>POLG,</i> which encodes the catalytic subunit of mitochondrial DNA polymerase gamma [<a class="bk_pop" href="#merrf.REF.van_goethem.2003.1811">Van Goethem et al 2003</a>].</div></li><li class="half_rhythm"><div><b><i>CARS2</i>-related disorder.</b> In two siblings with juvenile-onset MERRF-like severe myoclonus epilepsy who had ataxia, spastic tetraparesis, vision loss, hearing loss, and cognitive decline, a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> splice-site variant was identified in <i>CARS2</i>, which encodes mitochondrial cysteinyl-tRNA synthetase 2 [<a class="bk_pop" href="#merrf.REF.hallmann.2014.2183">Hallmann et al 2014</a>].</div></li><li class="half_rhythm"><div><b>MERRF/</b><a href="/books/n/gene/melas/"><b>MELAS</b></a>
<b>overlap syndrome,</b> which may initially resemble MERRF but is caused by pathogenic variants in either <i>MT-ND5</i> or <i>MT-TC</i> [<a class="bk_pop" href="#merrf.REF.crimi.2003.1857">Crimi et al 2003</a>, <a class="bk_pop" href="#merrf.REF.dimauro.2005.222">DiMauro &#x00026; Davidzon 2005</a>, <a class="bk_pop" href="#merrf.REF.naini.2005.473">Naini et al 2005</a>, <a class="bk_pop" href="#merrf.REF.herreromart_n.2010.471">Herrero-Mart&#x000ed;n et al 2010</a>]. One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with MERRF/MELAS overlap syndrome had two pathogenic variants: the <i>MT-TL1</i> variant m.3243A&#x0003e;G (the most frequent cause of MELAS) and the <i>MT-TK</i> variant m.8356T&#x0003e;C (a rare cause of MERRF) [<a class="bk_pop" href="#merrf.REF.nakamura.2010.659">Nakamura et al 2010</a>].</div></li><li class="half_rhythm"><div><b><i>MT-TL2</i>-related disorder.</b> One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual had clinical features of MERRF and neuropathy-ataxia-retinitis pigmentosa (NARP) caused by the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> m.12300G&#x0003e;A in <i>MT-TL2</i> encoding mitochondrial tRNALeu(CUN) (tRNA<sup>Leu(CUN)</sup>) [<a class="bk_pop" href="#merrf.REF.mart_njim_nez.2012.288">Mart&#x000ed;n-Jim&#x000e9;nez et al 2012</a>].</div></li><li class="half_rhythm"><div>Syndromes characterized by ataxia (e.g., <a href="/books/n/gene/drpla/">DRPLA</a>; see also <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>) and myoclonus epilepsy, including <a href="/books/n/gene/epm1/">Unverricht-Lundborg disease</a>, <a href="/books/n/gene/lafora/">Lafora disease</a>, neuronal ceroid lipofuscinosis, and sialidosis [<a class="bk_pop" href="#merrf.REF.zupanc.2004.156">Zupanc &#x00026; Legros 2004</a>]</div></li></ul><p>The multisystem involvement, lactic acidosis, evidence of maternal inheritance, and the muscle biopsy with RRF (ragged red fibers) distinguish MERRF from other conditions.</p><p><b>Lipomas.</b> Other syndromes that cause multiple lipomas (e.g., multiple symmetric lipomatosis [OMIM <a href="http://omim.org/entry/151800" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">151800</a>]) need to be considered.</p></div><div id="merrf.Management"><h2 id="_merrf_Management_">Management</h2><div id="merrf.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with MERRF (<i>m</i>yoclonic <i>e</i>pilepsy associated with <i>r</i>agged <i>r</i>ed <i>f</i>ibers), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Measurement of height and weight to assess growth</div></li><li class="half_rhythm"><div>Audiologic evaluation</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation</div></li><li class="half_rhythm"><div>Assessment of cognitive abilities</div></li><li class="half_rhythm"><div>Physical therapy assessment</div></li><li class="half_rhythm"><div>Neurologic evaluation, including MRI, MRS, and EEG if seizures are suspected</div></li><li class="half_rhythm"><div>Cardiac evaluation</div></li><li class="half_rhythm"><div>Clinical genetics consultation including <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a></div></li></ul></div><div id="merrf.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The seizure disorder can be treated with conventional anticonvulsant therapy. No controlled studies have compared the efficacy of different anticonvulsants. Levetiracetam, clonazepam, zonisamide, and valproic acid (VPA) have been used to treat myoclonic epilepsy; however, VPA may cause secondary carnitine deficiency and should be avoided or used with L-carnitine supplementation.</p><p>The myoclonus improved substantially in three of four individuals treated with levetiracetam [<a class="bk_pop" href="#merrf.REF.crest.2004.640">Crest et al 2004</a>, <a class="bk_pop" href="#merrf.REF.mancuso.2007.1058">Mancuso et al 2007</a>]. Clonazepam can also reduce myoclonus.</p><p>Physical therapy is helpful for any impaired motor abilities.</p><p>Aerobic exercise is helpful in MERRF and other mitochondrial diseases [<a class="bk_pop" href="#merrf.REF.taivassalo.2004.221">Taivassalo &#x00026; Haller 2004</a>].</p><p>Standard pharmacologic therapy is used to treat cardiac symptoms.</p></div><div id="merrf.Prevention_of_Primary_Manifestatio"><h3>Prevention of Primary Manifestations</h3><p>The administration of coenzyme Q<sub>10</sub> (CoQ<sub>10</sub>) (50-100 mg 3x/day) and L-carnitine (1000 mg 3x/day) has been of some benefit to some individuals. In a small randomized double-blind placebo-controlled study of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with heterogeneous mitochondrial diseases, CoQ<sub>10</sub> combined with creatine and lipoic acid produced modest benefits including slowing progression of ankle weakness and lower resting plasma lactate concentration [<a class="bk_pop" href="#merrf.REF.rodriguez.2007.235">Rodriguez et al 2007</a>].</p></div><div id="merrf.Surveillance"><h3>Surveillance</h3><p>Affected individuals and their at-risk relatives should be followed at regular intervals (e.g. every 6-12 months initially) to monitor progression of disease and the appearance of new symptoms.</p><ul><li class="half_rhythm"><div>Annual neurologic, ophthalmologic, cardiology (electrocardiogram and echocardiogram), and endocrinologic evaluations (fasting blood sugar and TSH) are recommended.</div></li><li class="half_rhythm"><div>If normal for three years, less frequent evaluations can be considered.</div></li></ul></div><div id="merrf.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Individuals with MERRF should avoid mitochondrial toxins including aminoglycoside antibiotics, linezolid, cigarettes, and alcohol. Valproic acid should be avoided in the treatment of seizures.</p></div><div id="merrf.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from institution of treatment and preventive measures.</p><p>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk relatives.</p><p>See <a href="#merrf.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="merrf.Pregnancy_Management"><h3>Pregnancy Management</h3><p>During pregnancy, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at-risk women should be monitored for diabetes mellitus and respiratory insufficiency, which may require therapeutic interventions.</p></div><div id="merrf.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>The transfer of nuclear DNA from fertilized oocytes or zygotes harboring a mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to a recipient enucleated recipient cell could theoretically prevent transmission of mtDNA diseases and proof of this concept has been demonstrated in pronuclear transfers from abnormally fertilized zygotes that were allowed to undergo several replications in vitro [<a class="bk_pop" href="#merrf.REF.craven.2010.82">Craven et al 2010</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="merrf.Genetic_Counseling"><h2 id="_merrf_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="merrf.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>MERRF is caused by pathogenic variants in mtDNA and is transmitted by maternal inheritance.</p></div><div id="merrf.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is not at risk of having the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>The mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (usually) has the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and may or may not have symptoms.</div></li><li class="half_rhythm"><div>Alternatively, the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> (somatic) mitochondrial <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs depends on the genetic status of the mother: if the mother has the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, all sibs of a proband will inherit the mtDNA pathogenic variant and may or may not have symptoms.</p><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>All offspring of females with an mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will inherit the pathogenic variant.</div></li><li class="half_rhythm"><div>Offspring of males with a mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are not at risk of inheriting the pathogenic variant.</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's mother: if the mother has an mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, her sibs and mother are also at risk.</p></div><div id="merrf.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#merrf.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Phenotypic variability.</b> The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of an individual with a mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> results from a combination of factors including the severity of the pathogenic variant, the percentage of mutated mitochondria (mutational load), and the organs and tissues in which they are found (tissue distribution). Different family members often inherit different percentages of mutated mtDNA and therefore can have a wide range of clinical symptoms.</p><p><b>Interpretation of testing results of asymptomatic at-risk family members</b> is extremely difficult. Prediction of <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> based on test results is not possible. Furthermore, absence of the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one tissue (e.g., blood) does not guarantee its absence in other tissues.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. Similarly, decisions about testing to determine the genetic status of at-risk asymptomatic family members are best made before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including general discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk; however, it is not possible to make specific predictions about the potential severity of disease in offspring.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="merrf.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for MERRF are possible.</p><p>Interpretation of prenatal diagnostic results is complex for the following reasons:</p><ul><li class="half_rhythm"><div>The mutational load in the mother's tissues and in fetal tissues sampled (i.e., amniocytes and chorionic villi) may not correspond to that of other fetal tissues.</div></li><li class="half_rhythm"><div>Prediction of <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, age of onset, severity, or rate of progression is not possible.</div></li></ul></div></div><div id="merrf.Resources"><h2 id="_merrf_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Myoclonic%20Epilepsy%20associated%20with%20Ragged%20Red%20Fibers&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myoclonic epilepsy associated with ragged red fibers</a></div></li><li class="half_rhythm"><div><b>United Mitochondrial Disease Foundation (UMDF)</b></div><div>8085 Saltsburg Road</div><div>Suite 201</div><div>Pittsburg PA 15239</div><div><b>Phone:</b> 888-317-8633 (toll-free); 412-793-8077</div><div><b>Fax:</b> 412-793-6477</div><div><b>Email:</b> info@umdf.org</div><div><a href="http://www.umdf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.umdf.org</a></div></li><li class="half_rhythm"><div><b>International Mito Patients</b></div><div><a href="https://www.mitopatients.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mitopatients.org</a></div></li><li class="half_rhythm"><div><b>Mito Foundation (formerly the Australian Mitochondrial Disease Foundation)</b></div><div>21 Mary Street</div><div>Suite 3</div><div>Surry Hills New South Wales 2010</div><div>Australia</div><div><b>Phone:</b> 61-1-300-977-180</div><div><b>Fax:</b> 61-2-9999-3474</div><div><b>Email:</b> info@mito.org.au</div><div><a href="https://www.mito.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mito.org.au</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>The Lily Foundation</b></div><div>31 Warren Park</div><div>Surrey CR6 9LD</div><div>United Kingdom</div><div><b>Phone:</b> 07947 257247</div><div><b>Fax:</b> 01883 623799</div><div><b>Email:</b> liz@thelilyfoundation.org.uk</div><div><a href="http://www.thelilyfoundation.org.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.thelilyfoundation.org.uk</a></div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: North American Mitochondrial Disease Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/namdc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Contact Registry</a></div></li></ul></div><div id="merrf.Molecular_Genetics"><h2 id="_merrf_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="merrf.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>MERRF: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1520/table/merrf.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__merrf.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_merrf.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_merrf.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_merrf.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_merrf.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_merrf.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><i>MT-TF</i></td><td headers="hd_b_merrf.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Mitochondrion</td><td headers="hd_b_merrf.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Not applicable</td><td headers="hd_b_merrf.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MT-TF[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MT-TF</a></td></tr><tr><td headers="hd_b_merrf.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><i>MT-TI</i></td><td headers="hd_b_merrf.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Mitochondrion</td><td headers="hd_b_merrf.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Not applicable</td><td headers="hd_b_merrf.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MT-TI[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MT-TI</a></td></tr><tr><td headers="hd_b_merrf.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><i>MT-TK</i></td><td headers="hd_b_merrf.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Mitochondrion</td><td headers="hd_b_merrf.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Not applicable</td><td headers="hd_b_merrf.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MT-TK[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MT-TK</a></td></tr><tr><td headers="hd_b_merrf.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><i>MT-TL1</i></td><td headers="hd_b_merrf.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Mitochondrion</td><td headers="hd_b_merrf.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Not applicable</td><td headers="hd_b_merrf.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MT-TL1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MT-TL1</a></td></tr><tr><td headers="hd_b_merrf.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><i>MT-TP</i></td><td headers="hd_b_merrf.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Mitochondrion</td><td headers="hd_b_merrf.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Not applicable</td><td headers="hd_b_merrf.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MT-TP[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MT-TP</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="merrf.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="merrf.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for MERRF (<a href="/omim/545000,590045,590050,590060,590070,590075" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1520/table/merrf.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__merrf.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/545000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">545000</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERRF</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/590045" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">590045</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSFER RNA, MITOCHONDRIAL, ISOLEUCINE; MTTI</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/590050" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">590050</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSFER RNA, MITOCHONDRIAL, LEUCINE, 1; MTTL1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/590060" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">590060</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSFER RNA, MITOCHONDRIAL, LYSINE; MTTK</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/590070" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">590070</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSFER RNA, MITOCHONDRIAL, PHENYLALANINE; MTTF</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/590075" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">590075</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSFER RNA, MITOCHONDRIAL, PROLINE; MTTP</td></tr></tbody></table></div></div><div id="merrf.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The origin of mtDNA pathogenic variants is uncertain. It is also unclear how the mtDNA single nucleotide variants cause MERRF. Using rho<sup>0</sup> cell lines (permanent human cell lines emptied of their mtDNA by exposure to ethidium bromide) repopulated with mitochondria harboring the m.8344A&#x0003e;G <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, <a class="bk_pop" href="#merrf.REF.chomyn.1991.2236">Chomyn et al [1991]</a> found that high mutational loads correlated with decreased protein synthesis, decreased oxygen consumption, and cytochrome <i>c</i> oxidase deficiency. The polypeptides containing higher numbers of lysine residues were more severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> by the pathogenic variant, suggesting that the <i>MT-TK</i> pathogenic variant directly inhibits protein synthesis. Similarly, cultured myotubes containing more than 85% mutated mtDNA showed decreased translation, especially of proteins containing large numbers of lysine residues. Cells harboring the m.8344A&#x0003e;G pathogenic variant contained decreased levels of tRNA<sup>Lys</sup> and aminoacylated tRNA<sup>Lys</sup>. The variant appears to be functionally recessive because only about 15% wild type mtDNA restores translation and cytochrome <i>c</i> oxidase activity to near-normal levels.</p><p><a class="bk_pop" href="#merrf.REF.masucci.1995.2872">Masucci et al [1995]</a> confirmed that protein synthesis and oxygen consumption were decreased in rho<sup>0</sup> cells repopulated with mtDNA harboring either the m.8344A&#x0003e;G or the m.8356T&#x0003e;C <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, and identified aberrant mitochondrial protein in both cell lines, which they attributed to ribosomal frame-shifting. Studies of engineered in vitro transcribed tRNA<sup>Lys</sup> mutants showed that the pathogenic variants associated with MERRF had no effect on lysylation efficiency whereas the two pathogenic variants associated with encephalomyopathies without typical MERRF features (m.8313G&#x0003e;A and m.8328G&#x0003e;A in <i>MT-TK</i>) severely impaired lysylation [<a class="bk_pop" href="#merrf.REF.sissler.2004.841">Sissler et al 2004</a>].</p><p><b>Gene structure.</b> The mitochondrial genome is 16,569 bp in length. See <a href="http://www.mitomap.org/MITOMAP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MITOMAP</a> for genes and nucleotide variants of the mitochondrion. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1520/#merrf.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Benign polymorphisms are especially frequent in mtDNA and are listed at <a href="http://www.mitomap.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MITOMAP</a>.</p><p><b>Pathogenic variants.</b> See <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">Table 3</a>.</p><ul><li class="half_rhythm"><div>The mitochondrial DNA (mtDNA) <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>MT-TK</i> encoding tRNA lysine (tRNA<sup>Lys</sup>) is the gene most commonly associated with MERRF.</div></li><li class="half_rhythm"><div>One individual with the MERRF <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> had the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.611G&#x0003e;A</a> in <i>MT-TF,</i> encoding tRNA phenylalanine (tRNA<sup>Phe</sup>) [<a class="bk_pop" href="#merrf.REF.mancuso.2004.2119">Mancuso et al 2004</a>].</div></li><li class="half_rhythm"><div>One child age eight years with the MERRF <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> had the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> m.4284G&#x0003e;A in <i>MT-TI</i>, encoding tRNA isoleucine (tRNA<sup>Ile</sup>) [<a class="bk_pop" href="#merrf.REF.hahn.2011.148">Hahn et al 2011</a>].</div></li><li class="half_rhythm"><div>One adult with progressive myoclonic epilepsy ragged-red fibers, hearing loss, and cognitive impairment had the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.4279A&#x0003e;G</a> in <i>MT-TI</i> [<a class="bk_pop" href="#merrf.REF.zsurka.2013.483">Zsurka et al 2013</a>].</div></li><li class="half_rhythm"><div>One individual presenting with the MERRF <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> had the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> m.3243A&#x0003e;G in <i>MT-TL1</i>, encoding tRNA leucine(UUR) (tRNA<sup>Leu(UUR)</sup>) [<a class="bk_pop" href="#merrf.REF.brackmann.2012.859">Brackmann et al 2012</a>].</div></li><li class="half_rhythm"><div>One individual presented with MERRF and pigmentary retinopathy caused by the <a class="figpopup" href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object" rid-figpopup="figmerrfTpathogenicvariantsinmitochond" rid-ob="figobmerrfTpathogenicvariantsinmitochond">m.15967G&#x0003e;A</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MT-TP</i> [<a class="bk_pop" href="#merrf.REF.blakely.2009.399">Blakely et al 2009</a>].</div></li></ul><div id="merrf.T.pathogenic_variants_in_mitochond" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Pathogenic Variants in Mitochondrial DNA Associated with MERRF</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1520/table/merrf.T.pathogenic_variants_in_mitochond/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__merrf.T.pathogenic_variants_in_mitochond_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrial DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequence</th></tr></thead><tbody><tr><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">m.8344A&#x0003e;G<br />(A8344G)</td><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_2" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TK</i></td><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_3" rowspan="10" colspan="1" style="text-align:left;vertical-align:middle;">No protein translated</td><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_4" rowspan="10" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/251831106" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NC_012920<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">m.8356T&#x0003e;C<br />(T8356C)</td></tr><tr><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">m.8363G&#x0003e;A<br />(G8363A)</td></tr><tr><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">m.8361G&#x0003e;A<br />(G8361A)</td></tr><tr><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">m.611G&#x0003e;A<br />(G611A)</td><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TF</i></td></tr><tr><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">m.3243A&#x0003e;G<br />(A3243G)</td><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TL1</i></td></tr><tr><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">m.4279A&#x0003e;G<br />(A4279G)</td><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TI</i></td></tr><tr><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">m.4284G&#x0003e;A<br />(G4284A)</td></tr><tr><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">m.15923A&#x0003e;G<br />(A15923G)</td><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TP</i></td></tr><tr><td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">m.15967G&#x0003e;A<br />(G15967A)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="merrf.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The genes encode tRNAs that are indispensable for the incorporation of these amino acids into nascent mitochondrial proteins:</p><div id="merrf.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1520/table/merrf.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__merrf.Td_lrgtbl__"><table><thead><tr><th id="hd_h_merrf.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_merrf.Td_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Amino Acid</th></tr></thead><tbody><tr><td headers="hd_h_merrf.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TK</i></td><td headers="hd_h_merrf.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrially encoded tRNA lysine</td></tr><tr><td headers="hd_h_merrf.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TF</i></td><td headers="hd_h_merrf.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrially encoded tRNA phenylalanine</td></tr><tr><td headers="hd_h_merrf.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TL1</i></td><td headers="hd_h_merrf.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrially encoded tRNA leucine UUR</td></tr><tr><td headers="hd_h_merrf.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TI</i></td><td headers="hd_h_merrf.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrially encoded tRNA threonine</td></tr><tr><td headers="hd_h_merrf.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TP</i></td><td headers="hd_h_merrf.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrially encoded tRNA proline</td></tr></tbody></table></div></div><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> See <a href="#merrf.Molecular_Pathogenesis">Molecular Pathogenesis</a>.</p></div></div><div id="merrf.References"><h2 id="_merrf_References_">References</h2><div id="merrf.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.blakely.2014.533">Blakely EL, Alston CL, Lecky B, Chakrabarti B, Falkous G, Turnbull DM, Taylor RW, Gorman GS. Distal weakness with respiratory insufficiency caused by the m.8344A &#x0003e; G "MERRF" mutation. <span><span class="ref-journal">Neuromuscul Disord. </span>2014;<span class="ref-vol">24</span>:533–6.</span> [<a href="/pmc/articles/PMC4047625/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4047625</span></a>] [<a href="/pubmed/24792523" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24792523</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.blakely.2009.399">Blakely EL, Trip SA, Swalwell H, He L, Wren DR, Rich P, Turnbull DM, Omer SE, Taylor RW. A new mitochondrial transfer RNAPro gene mutation associated with myoclonic epilepsy with ragged-red fibers and other neurological features. <span><span class="ref-journal">Arch Neurol. </span>2009;<span class="ref-vol">66</span>:399–402.</span> [<a href="/pubmed/19273760" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19273760</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.brackmann.2012.859">Brackmann F, Abicht A, Ahting U, Schroder R, Trollmann R. Classical MERRF phenotype associated with mitochondrial tRNA(Leu) (m.3243A&#x0003e;G) mutation. <span><span class="ref-journal">Eur J Pediatr. </span>2012;<span class="ref-vol">171</span>:859–62.</span> [<a href="/pubmed/22270878" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22270878</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.chomyn.1991.2236">Chomyn A, Meola G, Bresolin N, Lai ST, Scarlato G, Attardi G. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. <span><span class="ref-journal">Mol Cell Biol. </span>1991;<span class="ref-vol">11</span>:2236–44.</span> [<a href="/pmc/articles/PMC359920/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC359920</span></a>] [<a href="/pubmed/1848674" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1848674</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.craven.2010.82">Craven L, Tuppen HA, Greggains GD, Harbottle SJ, Murphy JL, Cree LM, Murdoch AP, Chinnery PF, Taylor RW, Lightowlers RN, Herbert M, Turnbull DM. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. <span><span class="ref-journal">Nature. </span>2010;<span class="ref-vol">465</span>:82–5.</span> [<a href="/pmc/articles/PMC2875160/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2875160</span></a>] [<a href="/pubmed/20393463" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20393463</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.crest.2004.640">Crest C, Dupont S, Leguern E, Adam C, Baulac M. Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:640–3.</span> [<a href="/pubmed/14981187" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14981187</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.crimi.2003.1857">Crimi M, Galbiati S, Moroni I, Bordoni A, Perini MP, Lamantea E, Sciacco M, Zeviani M, Biunno I, Moggio M, Scarlato G, Comi GP. A missense mutation in the mitochondrial ND5 gene associated with a Leigh-MELAS overlap syndrome. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">60</span>:1857–61.</span> [<a href="/pubmed/12796552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12796552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.darin.2001.377">Darin N, Oldfors A, Moslemi AR, Holme E, Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">49</span>:377–83.</span> [<a href="/pubmed/11261513" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11261513</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.dimauro.2005.222">DiMauro S, Davidzon G. Mitochondrial DNA and disease. <span><span class="ref-journal">Ann Med. </span>2005;<span class="ref-vol">37</span>:222–32.</span> [<a href="/pubmed/16019721" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16019721</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.emmanuele.2011.448">Emmanuele V, Silvers DS, Sotiriou E, Tanji K, DiMauro S, Hirano M. MERRF and Kearns-Sayre overlap syndrome due to the mitochondrial DNA m.3291T&#x0003e;C mutation. <span><span class="ref-journal">Muscle Nerve. </span>2011;<span class="ref-vol">44</span>:448–51.</span> [<a href="/pmc/articles/PMC3197731/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3197731</span></a>] [<a href="/pubmed/21996807" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21996807</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.erol.2009.275">Erol I, Alehan F, Horvath R, Schneiderat P, Talim B. Demyelinating disease of central and peripheral nervous systems associated with a A8344G mutation in tRNALys. <span><span class="ref-journal">Neuromuscul Disord. </span>2009;<span class="ref-vol">19</span>:275–8.</span> [<a href="/pubmed/19269823" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19269823</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.fujioka.2014.13">Fujioka H, Tandler B, Rosca M, McCandless SE, Katirji B, Cohen ML, Rapisuwon S, Hoppel CL. Multiple muscle cell alterations in a case of encephalomyopathy. <span><span class="ref-journal">Ultrastruct Pathol. </span>2014;<span class="ref-vol">38</span>:13–25.</span> [<a href="/pubmed/24134831" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24134831</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.hahn.2011.148">Hahn A, Schanzer A, Neubauer BA, Gizewski E, Ahting U, Rolinski B. MERRF-like phenotype associated with a rare mitochondrial tRNAIle mutation (m.4284 G&#x0003e;A). <span><span class="ref-journal">Neuropediatrics. </span>2011;<span class="ref-vol">42</span>:148–51.</span> [<a href="/pubmed/21766266" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21766266</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.hallmann.2014.2183">Hallmann K, Zsurka G, Moskau-Hartmann S, Kirschner J, Korinthenberg R, Ruppert AK, Ozdemir O, Weber Y, Becker F, Lerche H, Elger CE, Thiele H, Nurnberg P, Sander T, Kunz WS. A homozygous splice-site mutation in CARS2 is associated with progressive myoclonic epilepsy. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">83</span>:2183–7.</span> [<a href="/pubmed/25361775" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25361775</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.herreromart_n.2010.471">Herrero-Mart&#x000ed;n MD, Ayuso T, Tu&#x000f1;&#x000f3;n MT, Mart&#x000ed;n MA, Ruiz-Pesini E, Montoya J. A. MELAS/MERRF phenotype associated with the mitochondrial DNA 5521G&#x0003e;A mutation. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2010;<span class="ref-vol">81</span>:471–2.</span> [<a href="/pubmed/20360171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20360171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.hirano.1996">Hirano M, DiMauro S. Clinical features of mitochondrial myopathies and encephalomyopathies. In: Lane RJM, ed. <em>Handbook of Muscle Disease</em>. New York, NY: Marcel Dekker Inc; 1996:479-504.</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.horvath.2007.56">Horvath R, Kley RA, Lochmuller H, Vorgerd M. Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">68</span>:56–58.</span> [<a href="/pubmed/17200493" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17200493</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.hunt.1921.490">Hunt JR. Dyssynergia cerebellaris myoclonia-primary atrophy of the dentate system: a contribution to the pathology and symptomatology of the cerebellum. <span><span class="ref-journal">Brain. </span>1921;<span class="ref-vol">44</span>:490–538.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.ito.2008.392">Ito S, Shirai W, Asahina M, Hattori T. Clinical and brain MR imaging features focusing on the brain stem and cerebellum in patients with myoclonic epilepsy with ragged-red fibers due to mitochondrial A8344G mutation. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2008;<span class="ref-vol">29</span>:392–5.</span> [<a href="/pubmed/17989367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17989367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.mancuso.2004.2119">Mancuso M, Filosto M, Mootha VK, Rocchi A, Pistolesi S, Murri L, DiMauro S, Siciliano G. A novel mitochondrial tRNAPhe mutation causes MERRF syndrome. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:2119–21.</span> [<a href="/pubmed/15184630" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15184630</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.mancuso.2013.2049">Mancuso M, Orsucci D, Angelini C, Bertini E, Carelli V, Comi GP, Minetti C, Moggio M, Mongini T, Servidei S, Tonin P, Toscano A, Uziel G, Bruno C, Caldarazzo Ienco E, Filosto M, Lamperti C, Martinelli D, Moroni I, Musumeci O, Pegoraro E, Ronchi D, Santorelli FM, Sauchelli D, Scarpelli M, Sciacco M, Spinazzi M, Valentino ML, Vercelli L, Zeviani M, Siciliano G. Phenotypic heterogeneity of the 8344A&#x0003e;G mtDNA "MERRF" mutation. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">80</span>:2049–54.</span> [<a href="/pubmed/23635963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23635963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.mancuso.2007.1058">Mancuso M, Petrozzi L, Filosto M, Nesti C, Rocchi A, Choub A, Pistolesi S, Massentani R, Fontanini G, Siciliano G. MERRF syndrome without ragged-red fibers: the need for molecular diagnosis. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2007;<span class="ref-vol">354</span>:1058–60.</span> [<a href="/pubmed/17275787" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17275787</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.mart_njim_nez.2012.288">Mart&#x000ed;n-Jim&#x000e9;nez R, Martin-Hernandez E, Cabello A, Garcia-Silva MT, Arenas J, Campos Y. Clinical and cellular consequences of the mutation m.12300G&#x0003e;A in the mitochondrial tRNA(Leu(CUN)) gene. <span><span class="ref-journal">Mitochondrion. </span>2012;<span class="ref-vol">12</span>:288–93.</span> [<a href="/pubmed/22094595" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22094595</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.masucci.1995.2872">Masucci JP, Davidson M, Koga Y, Schon EA, King MP. In vitro analysis of mutations causing myoclonus epilepsy with ragged-red fibers in the mitochondrial tRNA(Lys)gene: two genotypes produce similar phenotypes. <span><span class="ref-journal">Mol Cell Biol. </span>1995;<span class="ref-vol">15</span>:2872–81.</span> [<a href="/pmc/articles/PMC230518/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC230518</span></a>] [<a href="/pubmed/7739567" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7739567</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.melone.2004.269">Melone MA, Tessa A, Petrini S, Lus G, Sampaolo S, di Fede G, Santorelli FM, Cotrufo R. Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERRF phenotype. <span><span class="ref-journal">Arch Neurol. </span>2004;<span class="ref-vol">61</span>:269–72.</span> [<a href="/pubmed/14967777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14967777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.molnar.2009.264">Molnar MJ, Perenyi J, Siska E, Nemeth G, Nagy Z. The typical MERRF (A8344G) mutation of the mitochondrial DNA associated with depressive mood disorders. <span><span class="ref-journal">J Neurol. </span>2009;<span class="ref-vol">256</span>:264–5.</span> [<a href="/pubmed/19266142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19266142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.naini.2005.473">Naini AB, Lu J, Kaufmann P, Bernstein RA, Mancuso M, Bonilla E, Hirano M, DiMauro S. Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF. <span><span class="ref-journal">Arch Neurol. </span>2005;<span class="ref-vol">62</span>:473–6.</span> [<a href="/pubmed/15767514" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15767514</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.nakamura.2010.659">Nakamura M, Yabe I, Sudo A, Hosoki K, Yaguchi H, Saitoh S, Sasaki H. MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:659–64.</span> [<a href="/pubmed/20610441" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20610441</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.nishigaki.2003.334">Nishigaki Y, Tadesse S, Bonilla E, Shungu D, Hersh S, Keats BJ, Berlin CI, Goldberg MF, Vockley J, DiMauro S, Hirano M. A novel mitochondrial tRNA(Leu(UUR)) mutation in a patient with features of MERRF and Kearns-Sayre syndrome. <span><span class="ref-journal">Neuromuscul Disord. </span>2003;<span class="ref-vol">13</span>:334–40.</span> [<a href="/pubmed/12868503" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12868503</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.orcesi.2006.79">Orcesi S, Gorni K, Termine C, Uggetti C, Veggiotti P, Carrara F, Zeviani M, Berardinelli A, Lanzi G. Bilateral putaminal necrosis associated with the mitochondrial DNA A8344G myoclonus epilepsy with ragged red fibers (MERRF) mutation: an infantile case. <span><span class="ref-journal">J Child Neurol. </span>2006;<span class="ref-vol">21</span>:79–82.</span> [<a href="/pubmed/16551460" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16551460</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.peng.2003.716">Peng Y, Crumley R, Ringman JM. Spasmodic dysphonia in a patient with the A to G transition at nucleotide 8344 in mitochondrial DNA. <span><span class="ref-journal">Mov Disord. </span>2003;<span class="ref-vol">18</span>:716–8.</span> [<a href="/pubmed/12784281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12784281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.remes.2005.976">Remes AM, Majamaa-Voltti K, Karppa M, Moilanen JS, Uimonen S, Helander H, Rusanen H, Salmela PI, Sorri M, Hassinen IE, Majamaa K. Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:976–81.</span> [<a href="/pubmed/15781811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15781811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.rodriguez.2007.235">Rodriguez MC, MacDonald JR, Mahoney DJ, Parise G, Beal MF, Tarnopolsky MA. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. <span><span class="ref-journal">Muscle Nerve. </span>2007;<span class="ref-vol">35</span>:235–42.</span> [<a href="/pubmed/17080429" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17080429</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.rossmanith.2003.820">Rossmanith W, Raffelsberger T, Roka J, Kornek B, Feucht M, Bittner RE. The expanding mutational spectrum of MERRF substitution G8361A in the mitochondrial tRNALys gene. <span><span class="ref-journal">Ann Neurol. </span>2003;<span class="ref-vol">54</span>:820–3.</span> [<a href="/pubmed/14681892" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14681892</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.schaefer.2008.35">Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, Taylor RW, Chinnery PF, Turnbull DM. Prevalence of mitochondrial DNA disease in adults. <span><span class="ref-journal">Ann Neurol. </span>2008;<span class="ref-vol">63</span>:35–9.</span> [<a href="/pubmed/17886296" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17886296</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.shtilbans.2000.759">Shtilbans A, Shanske S, Goodman S, Sue CM, Bruno C, Johnson TL, Lava NS, Waheed N, DiMauro S. G8363A mutation in the mitochondrial DNA transfer ribonucleic acidLys gene: another cause of Leigh syndrome. <span><span class="ref-journal">J Child Neurol. </span>2000;<span class="ref-vol">15</span>:759–61.</span> [<a href="/pubmed/11108511" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11108511</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.sissler.2004.841">Sissler M, Helm M, Frugier M, Giege R, Florentz C. Aminoacylation properties of pathology-related human mitochondrial tRNA(Lys) variants. <span><span class="ref-journal">RNA. </span>2004;<span class="ref-vol">10</span>:841–53.</span> [<a href="/pmc/articles/PMC1370574/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1370574</span></a>] [<a href="/pubmed/15100439" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15100439</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.taivassalo.2004.221">Taivassalo T, Haller RG. Implications of exercise training in mtDNA defects--use it or lose it? <span><span class="ref-journal">Biochim Biophys Acta. </span>2004;<span class="ref-vol">1659</span>:221–31.</span> [<a href="/pubmed/15576055" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15576055</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.vallance.2004.538">Vallance HD, Jeven G, Wallace DC, Brown MD. A case of sporadic infantile histiocytoid cardiomyopathy caused by the A8344G (MERRF) mitochondrial DNA mutation. <span><span class="ref-journal">Pediatr Cardiol. </span>2004;<span class="ref-vol">25</span>:538–40.</span> [<a href="/pubmed/15164143" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15164143</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.van_de_glind.2007.243">van de Glind G, de Vries M, Rodenburg R, Hol F, Smeitink J, Morava E. Resting muscle pain as the first clinical symptom in children carrying the MTTK A8344G mutation. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2007;<span class="ref-vol">11</span>:243–6.</span> [<a href="/pubmed/17293137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17293137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.van_goethem.2003.1811">Van Goethem G, Mercelis R, L&#x000f6;fgren A, Seneca S, Ceuterick C, Martin JJ, Van Broeckhoven C. Patient homozygous for a recessive POLG mutation presents with features of MERRF. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">61</span>:1811–3.</span> [<a href="/pubmed/14694057" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14694057</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.vastagh.2011.399">Vastagh I, Gal A, Remenyi V, Semjen J, Lukacs T, Valikovics A, Molnar MJ. A8344G mutation of the mitochondrial DNA with typical mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome. <span><span class="ref-journal">Ideggyogy Sz. </span>2011;<span class="ref-vol">64</span>:399–403.</span> [<a href="/pubmed/22611618" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22611618</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.wahbi.2010.674">Wahbi K, Larue S, Jardel C, Meune C, Stojkovic T, Ziegler F, Lombes A, Eymard B, Duboc D, Laforet P. Cardiac involvement is frequent in patients with the m.8344A&#x0003e;G mutation of mitochondrial DNA. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">74</span>:674–7.</span> [<a href="/pubmed/20177121" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20177121</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.wiedemann.2008.859">Wiedemann FR, Bartels C, Kirches E, Mawrin C, Wallesch CW. Unusual presentations of patients with the mitochondrial MERRF mutation A8344G. <span><span class="ref-journal">Clin Neurol Neurosurg. </span>2008;<span class="ref-vol">110</span>:859–63.</span> [<a href="/pubmed/18657354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18657354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.yoon.1993.433">Yoon KL, Ernst SG, Rasmussen C, Dooling EC, Aprille JR. Mitochondrial disorder associated with newborn cardiopulmonary arrest. <span><span class="ref-journal">Pediatr Res. </span>1993;<span class="ref-vol">33</span>:433–40.</span> [<a href="/pubmed/8511015" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8511015</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.yorns.2012.398">Yorns WR Jr, Valencia I, Jayaraman A, Sheth S, Legido A, Goldenthal MJ. Buccal swab analysis of mitochondrial enzyme deficiency and DNA defects in a child with suspected myoclonic epilepsy and ragged red fibers (MERRF). <span><span class="ref-journal">J Child Neurol. </span>2012;<span class="ref-vol">27</span>:398–401.</span> [<a href="/pubmed/22114216" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22114216</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.zsurka.2013.483">Zsurka G, Becker F, Heinen M, Gdynia HJ, Lerche H, Kunz WS, Weber YG. Mutation in the mitochondrial tRNA(Ile) gene causes progressive myoclonus epilepsy. <span><span class="ref-journal">Seizure. </span>2013;<span class="ref-vol">22</span>:483–6.</span> [<a href="/pubmed/23601850" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23601850</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="merrf.REF.zupanc.2004.156">Zupanc ML, Legros B. Progressive myoclonic epilepsy. <span><span class="ref-journal">Cerebellum. </span>2004;<span class="ref-vol">3</span>:156–71.</span> [<a href="/pubmed/15543806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15543806</span></a>]</div></li></ul></div></div><div id="merrf.Chapter_Notes"><h2 id="_merrf_Chapter_Notes_">Chapter Notes</h2><div id="merrf.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>29 January 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 August 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 September 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 June 2003 (ca) Review posted live</div></li><li class="half_rhythm"><div>8 May 2003 (sdm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1520</span><span class="label">PMID: <a href="/pubmed/20301693" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301693</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/melas/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mpph/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1520&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1520/?report=reader">PubReader</a></li><li><a href="/books/NBK1520/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1520" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1520" style="display:none" title="Cite this Page"><div class="bk_tt">DiMauro S, Hirano M. MERRF. 2003 Jun 3 [Updated 2015 Jan 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1520/pdf/Bookshelf_NBK1520.pdf">PDF version of this page</a> (228K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#merrf.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#merrf.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#merrf.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#merrf.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#merrf.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#merrf.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#merrf.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#merrf.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#merrf.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#merrf.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#merrf.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4566[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TK</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4565[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TI</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4567[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TL1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4558[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TF</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4571[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1497102" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1497102" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1497102" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301411" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> MELAS</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> MELAS<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">El-Hattab AW, Almannai M, Scaglia F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301403" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial Disorders Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial Disorders Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chinnery PF. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301352" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial DNA-Associated Leigh Syndrome and NARP</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial DNA-Associated Leigh Syndrome and NARP<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Thorburn DR, Rahman J, Rahman S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301353" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leber Hereditary Optic Neuropathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leber Hereditary Optic Neuropathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yu-Wai-Man P, Chinnery PF. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301595" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Nonsyndromic Hearing Loss and Deafness, Mitochondrial</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Nonsyndromic Hearing Loss and Deafness, Mitochondrial<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Usami S, Nishio S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301693" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301693" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04151075f66d18aa3f0851">MERRF - GeneReviews®</a><div class="ralinkpop offscreen_noflow">MERRF - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:04:00-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE899FEAE04128A10000000001490094&amp;ncbi_session=CE899FEAE04150F1_0329SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1520%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1520&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1520/&amp;ncbi_pagename=MERRF - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE899FEAE04150F1_0329SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>